Genscript Corporation Finishes Year with Successful Hong Kong IPO

PISCATAWAY, N.J.–(BUSINESS WIRE)–Genscript Biotech Corporation, the number one global provider of gene synthesis services and a strong player in synthetic biology, ended 2015 with a successful IPO on the Hong Kong exchange.


Print Friendly, PDF & Email

Share This

Share this post with your friends!